ACPMP Sponsors First-Ever International Pathology Standard for Appendix Tumors

The ACPMP Research Foundation is proud to announce the publication of the first-ever international pathology reporting standard dedicated to tumors of the appendix. It was developed by the International Collaboration on Cancer Reporting (ICCR) with sponsorship from ACPMP.

Why this matters

When someone is diagnosed with an appendix tumor, the pathology report is one of the most important documents in their care. It describes what kind of tumor it is, how aggressive it looks, and whether it has spread, and doctors use that information to plan treatment.

But appendix tumors are rare, and pathology reports for them have often been inconsistent. The same tumor might be described with different terms depending on where it was reviewed, and some of those terms can sound more alarming than the diagnosis really is. For patients and families reading their own reports, that confusion can be frightening.

The new ICCR standard addresses this by giving pathologists around the world a common framework for appendix tumor reports.

What the new standard covers

The ICCR Tumours of the Appendix Histopathology Reporting Guide sets out what pathologists should document when reporting appendix tumors, including:

  • Tumor type, such as low-grade or high-grade appendiceal mucinous neoplasms (LAMN and HAMN), mucinous adenocarcinoma, and goblet cell adenocarcinoma
  • Tumor grade, or how abnormal the cells appear
  • Pattern of invasion, which helps distinguish a true cancer from a mucinous neoplasm
  • Extent of disease, including spread within the abdomen (peritoneum), the grade of any disease there, and whether lymph nodes are involved
  • Surgical details, such as the type of surgery, tumor size, perforation and margins
  • Testing for future treatment decisions, including mismatch repair (MMR) status and preserving tissue for future molecular testing

The standard was developed alongside the World Health Organization’s updated classification of digestive system tumors, so pathologists can use consistent terminology and criteria.

Developed by international experts

The standard was written by an international committee of leading pathologists and surgeons. Members include ACPMP Medical Advisory Board Chair Dr. Laura Lambert of NYU Langone Health, Medical Advisory Board member Dr. Reetesh Pai of the University of Pittsburgh School of Medicine/UPMC, and Dr. Kiran Turaga of Yale School of Medicine. A draft was released for public comment earlier this year before the final version was published.

Free and available worldwide

The standard is free online, so any pathologist anywhere in the world can use it. Patients can share it with their care team and ask whether their pathology report follows it.

Part of ACPMP’s mission

Sponsoring this work is part of ACPMP’s commitment to advancing research and education for appendix cancer and pseudomyxoma peritonei (PMP). Clear, consistent pathology reporting helps patients get an accurate diagnosis, helps doctors choose the right treatment, and gives researchers consistent data to build on.

ACPMP thanks the ICCR and every member of the expert committee for their work on this landmark resource.

View the ICCR Tumours of the Appendix Histopathology Reporting Guide